Differential modulation of human basophil functions through prostaglandin D2 receptors DP and chemoattractant receptor-homologous molecule expressed on Th2 cells/DP2

Clinical and Experimental Allergy

Volumn 34, Issue 8, 2004, Pages 1283-1290

  Yoshimura Uchiyama, C ^a   Iikura, M ^a   Yamaguchi, M ^a   Nagase, H ^a   Ishii, A ^a   Matsushima, K ^a   Yamamoto, K ^a   Shichijo, M ^b   Bacon, K B ^b   Hirai, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b Research Center Kyoto   (Japan)

Author keywords

Apoptosis; Basophils; Ca2+ influx; Cd11b; Chemotaxis; CRTH2; Degranulation; DP; Eosinophils; Prostaglandin

Indexed keywords

13,14 DIHYDRO 15 OXOPROSTAGLANDIN D2; 3 BENZYL 5 (6 CARBOXYHEXYL) 1 (2 CYCLOHEXYL 2 HYDROXYETHYLAMINO)HYDANTOIN; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; CD11 ANTIGEN; CHEMOATTRACTANT; IMMUNOGLOBULIN E; MESSENGER RNA; PROSTAGLANDIN D2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; RAMATROBAN; UNCLASSIFIED DRUG;

ALLERGY; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BASOPHIL; BASOPHIL DEGRANULATION; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL SURVIVAL; CHEMORECEPTOR; CHEMOTAXIS; CONTROLLED STUDY; DRUG INHIBITION; GENE EXPRESSION; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE MIGRATION; MIGRATION INHIBITION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TH2 CELL; UPREGULATION;

ANTIGENS, CD11B; BASOPHILS; CALCIUM; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; CHEMOTAXIS; HISTAMINE RELEASE; HUMANS; HYDANTOINS; HYPERSENSITIVITY; PROSTAGLANDIN D2; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH2 CELLS;

EID: 4143121034     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2004.02027.x     Document Type: Article

References (27)

1. Naclerio RM, Proud D, Togias AG et al. Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985; 313:65-70.
2. Charlesworth EN, Hood AF, Soter NA, Kagey-Sobotka A, Norman PS, Lichtenstein LM. Cutaneous late-phase response to allergen. Mediator release and inflammatory cell infiltration. J Clin Invest 1989; 83:1519-26.
3. Irani AM, Huang C, Xia HZ et al. Immunohistochemical detection of human basophils in late-phase skin reactions. J Allergy Clin Immunol 1998; 101:354-62.
4. Ying S, Robinson DS, Meng Q et al. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES). J Immunol 1999; 163:3976-84.
5. Gauvreau GM, Lee JM, Watson RM, Irani AM, Schwanz LB, O'Byrne PM. Increased numbers of both airway basophils and mast cells in sputum after allergen inhalation challenge of atopic asthmatics. Am J Respir Crit Care Med 2000; 161:1473-8.
6. Urade Y, Hayaishi O. Prostaglandin D synthase: structure and function. Vitam Horm 2000; 58:89-120.
7. Murray JJ, Tonnel AB, Brash AR et al. Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med 1986; 315:800-4.
8. Peters SP, Kagey-Sobotka A, MacGlashan DW Jr., Lichtenstein LM. Effect of prostaglandin D2 in modulating histamine release from human basophils. J Pharmacol Exp Ther 1984; 228:400-6.
9. Hirai H, Tanaka K, Yoshie O et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med 2001; 193:255-61.
10. Hirata M, Kakizuka A, Aizawa M, Ushikubi F, Narumiya S. Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proc Natl Acad Sci USA 1994; 91:11192-6.
11. Boie Y, Sawyer N, Slipetz DM, Metters KM, Abramovitz M. Molecular cloning and characterization of the human prostanoid DP receptor. J Biol Chem 1995; 270:18910-6.
12. Monneret G, Gravel S, Diamond M, Rokach J, Powell WS. Prostaglandin D2 is a potent chemoattractant for human eosinophils that acts via a novel DP receptor. Blood 2001; 98:1942-8.
13. Sawyer N, Cauchon E, Chateauneuf A et al. Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2. Br J Pharmacol 2002; 137:1163-72.
14. Yoshimura C, Yamaguchi M, Iikura M et al. Activation markers of human basophils: CD69 expression is strongly and preferentially induced by IL-3. J Allergy Clin Immunol 2002; 109:817-23.
15. Hirai K, Miyamasu M, Yamaguchi M et al. Modulation of human basophil histamine release by insulin-like growth factors. J Immunol 1993; 150:1503-8.
16. Iikura M, Miyamasu M, Yamaguchi M et al. Chemokine receptors in human basophils: inducible expression of functional CXCR4. J Leukoc Biol 2001; 70:113-20.
17. Yoshimura C, Miyamasu M, Nagase H et al. Glucocorticoids induce basophil apoptosis. J Allergy Clin Immunol 2001; 108:215-20.
18. Yoshimura-Uchiyama C, Yamaguchi M, Nagase H et al. Comparative effects of basophil-directed growth factors. Biochem Biophys Res Commun 2003; 302:201-6.
19. Hirai K, Miyamasu M, Takaishi T, Morita Y. Regulation of the function of eosinophils and basophils. Crit Rev Immunol 1997; 17:325-52.
20. Sugimoto H, Shichijo M, Iino T et al. An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro. J Pharmacol Exp Ther 2003; 305:347-52.
21. Angeli V, Faveeuw C, Roye O et al. Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J Exp Med 2001; 193:1135-47.
22. Kaneko T, Alvarez R, Ueki IF, Nadel JA. Elevated intracellular cyclic AMP inhibits chemotaxis in human eosinophils. Cell Signal 1995; 7:527-34.
23. Yamaguchi M, Hirai K, Ohta K, Ito K, Morita Y. A beta 2-agonist, procaterol, inhibits basophil migration. J Asthma 1995; 32:125-30.
24. Peachell PT, MacGlashan DW Jr., Lichtenstein LM, Schleimer RP. Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. J Immunol 1988; 140:571-9.
25. Gervais FG, Cruz RP, Chateauneuf A et al. Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J Allergy Clin Immunol 2001; 108:982-8.
26. Ward C, Dransfield I, Murray J, Farrow SN, Haslett C, Rossi AG. Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I kappa B alpha degradation using a peroxisome proliferator-activated receptor-gamma-independent mechanism. J Immunol 2002; 168:6232-43.
27. Matsuoka T, Hirata M, Tanaka H et al. Prostaglandin D2 as a mediator of allergic asthma. Science 2000; 287:2013-7.